Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA - Quiz - MDSpire

Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA

  • By

  • Royston Ponraj

  • Adam Bryant

  • Lindsay Dunlop

  • Heather Range

  • Cherry Cobrador

  • Silvia Ling

  • Danny Hsu

  • July 26, 2023

  • 0 min

Share

Original Source(s)

Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA

  • by Royston Ponraj, Adam Bryant, Lindsay Dunlop, Heather Range, Cherry Cobrador, Silvia Ling, Danny Hsu

  • July 26, 2023

Related Content

Differential expression of immune activation markers in T cells from patients with multiple myeloma

Association of genetic ancestry with outcomes and toxicity of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma

Not all plasma cells are made equal: well-hidden layers of heterogeneity